IJREH | Risk Factors Associations of Metabolic Syndrome

Indexing and Abstracting

Risk Factors Associations of Metabolic Syndrome

Dr. Noaman Abdulateef Abdulrazzaq , Mustafa Mamon Ahmed , Farah Thamer Hasan

International Journal of Rural Development, Environment and Health Research(IJREH), Vol-6,Issue-6, November - December 2022, Pages 1-4, 10.22161/ijreh.6.6.1

Download | Downloads : 10 | Total View : 594

Article Info: Received: 10 Oct 2022; Received in revised form: 01 Nov 2022; Accepted: 08 Nov 2022; Available online: 13 Nov 2022

Abstract:

Background: Metabolic syndrome (syndrome x) A clustering of dyslipidemia , elevated blood pressure , impaired glucose tolerance , and central obesity which was varied somewhat in specific elements ,but in general they include a combination of multiple and metabolic risk factors. The most widely recognized risk factors are elevated blood pressure, atherogenic dyslipidemia, and elevated plasma glucose. Regardless of the cause, the syndrome recognized individuals at an elevation of these risk factors. The magnitude of increased risk can vary according to the components of the syndrome present as well as the other, non-metabolic syndrome risk factors in a particular person. The association of the metabolic syndrome with demographic characteristics and the metabolic syndrome risk increased with age, BMI and weight gain which are another important risk factors. Obesity has consistently been reported as a risk factor for metabolic syndrome, it is an important, easily observed, and measurable risk factor .it was the only fact that remained significantly associated with metabolic syndrome in all age, race and sex groups. Higher BMI and weight gain over time are associated with poorer blood pressure, higher fasting blood glucose, and dyslipidemia with the remaining atherosclerotic changes complications (hypertension CVD, and nephropathy) have been found to be associated with this syndrome.

Keywords:

metabolic syndrome, dyslipidemia, obesity, risk factors.

References:

[1] Pollex.RL and Hegele.RA”Genetic determination of metabolic syndrome”Nat clin pract cardiovas Med vol(3) No 9 pp482-489.2006.
[2] Ford.ES;Giles.WH,and Dietz.WH.”Prevelence of metabolic syndrome among US adults”JAMA vol 287No3pp356-359.2002.
[3] Sattar . N,and Scherbakova.O”metabolic syndrome with and without c-reactive protein as a predecter of coronary heart disease and diabetes in the west Scotland coronaryprevention study”circulation vol 108 pp 414-419.2003.
[4] Katzmaryk. PT;leon.A: Wilmore.JH;Shinner.JS; Rao.DC;Rankinin.T,and Bouchard.C ”Targeting the metabolic syndrome with exercise ”HERITAG family study “med sci sport exer..Vol 35 No10 pp1703-1709.2003.
[5] Fauci.A”Harison’sprinciples of internal medicine “Mc Graw –Hill medical .ISBNO.O7-147692-X.2008.
[6] Renaldi.O;Pramono.B;Sinorital.H;Purnomo.LB,and Aside .AH”Hypoadeponectinemia:a risk factore for metabolic syndrome”Acto med Indones vol 41 No 1 pp 20-24 .2009.
[7] Hall. JE. Crook,Jones.DW; Wofford.MR,and Dubbert. PM. Mechanismof obesity –associated cardiovascular and renal disease “.AMJ Med Sci vol 324 pp 127-137.2002.
[8] Sowers. JR” insulin resistance and hypertension “ AMJ physiol Heart Circ physiol vol 286 pp 1597-1602.2004.
[9] Toncer.G;Millci .B;Toncer.S,and Samardzic .G”Serum uric acid levels in multiple sclerosis patients correlate with activity and blood –brain barrier dysfunction . vol 3 pp 221-226.2002.
[10] Toncev.DB”Theraputic value of serum uric acid levels increasing in the treatement of multiple sclerosis”Vonjosanitekski pregled vol 163 No10 pp 879-882.2006.
[11] Dehghan.A;Von Hock. M; Sijbrands.EJ;Hofman.A,and Witteman.JC;”High serum uric acid as a novel risk factor type 2 diabetes “.Diabetes care (31)(2)361-5621t 2008.
[12] Aringer.M,and Grasseler .Understanding deficient elimination of uric acid”Lncet vol 372(9654):pp 1929-1938.2008.
[13] Gohill. BC; Rosenblom. LA; Coplan. JD, and Kral .JK”Hypothalamic- pituitary- adrenal axis function and metabolic syndrome x of obesity “CNS spect.vol 6 No 7 p581-589.2001.
[14] Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection , Evaluation ,and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel 111).JAMA 285:2486-2497,2001.